Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time
07 November 2023 - 10:01PM
AllPennyStocks.com
There are very good reasons that stocks
generally gain in value after a company receives orphan drug
designation (ODD). A
To read the full story on AllPennyStocks.com, click
here.
Nurexone Biologic (TSXV:NRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Nurexone Biologic (TSXV:NRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
